← Open Payments lookup

PREETI SODHI: Open Payments

NPI 1033268065 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$860 in 47 payments from 7 companies in 2025. Trend: 2023 $374 · 2024 $1,092 · 2025 $860

Food & beverage: $860
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$235
Otsuka America Pharmaceutical, Inc.18$218
Supernus Pharmaceuticals, Inc.1$111
Teva Pharmaceuticals USA, Inc.5$92
Janssen Pharmaceuticals, Inc4$87
E.R. Squibb & Sons, L.L.C.4$71
Lundbeck LLC3$45

Products named: CAPLYTA, REXULTI, Qelbree, UZEDY, INVEGA SUSTENNA, COBENFY, ABILIFY ASIMTUFII, ABILIFY MAINTENA.

Industry payments across TX — which companies pay providers there.